Study finds a better way to screen for breast cancerStudy finds a better way to screen for breast cancer
A pioneering study has found that an individualized approach to breast cancer screening that assesses patients’ risk, rather than annual mammograms, can lower the chance of more advanced cancers, while still safely match people to the amount of screening they need.
GLP-1s and Obesity Cancers; Cannabis’ New Legal Status; Celebrity Cancer DiagnosesGLP-1s and Obesity Cancers; Cannabis’ New Legal Status; Celebrity Cancer Diagnoses
(MedPage Today) — GLP-1 agonists may have little impact on risk of obesity-related cancers, according to a systematic review and meta-analysis of randomized studies. (Annals of Internal Medicine) The FDA granted accelerated approval for the subcutaneous… (MedPage Today) — GLP-1 agonists may have little impact on risk of obesity-related cancers, according to a systematic Read More
Anastrozole, Letrozole, and Exemestane in Postmenopausal Breast CancerAnastrozole, Letrozole, and Exemestane in Postmenopausal Breast Cancer
This comparative effectiveness research compares disease-free survival and overall survival 5 and 8 years after the initiation of endocrine therapy in postmenopausal women with hormone receptor–positive early-stage breast cancer.
Differential Effectiveness of Aromatase Inhibitors in HR-Positive Breast CancerDifferential Effectiveness of Aromatase Inhibitors in HR-Positive Breast Cancer
Oncology
Rb1 identified as predictive biomarker for new therapeutic strategy in some breast cancersRb1 identified as predictive biomarker for new therapeutic strategy in some breast cancers
A new study published in Science Translational Medicine by researchers at The University of Texas MD Anderson Cancer Center details a therapeutic vulnerability in patients with an aggressive subtype of triple-negative breast cancer.
Incretin Therapies After Bariatric Surgery Linked to Lower Risk of Alcohol DisorderIncretin Therapies After Bariatric Surgery Linked to Lower Risk of Alcohol Disorder
(MedPage Today) — Treatment with incretin-based weight-loss medications, like GLP-1 receptor agonists, after bariatric surgery was associated with significantly lower risks of alcohol use disorder (AUD) and initiation of medications for AUD compared…
Overcoming CDK4/6 Inhibitor Resistance in HR-Positive/HER2-Negative Breast CancerOvercoming CDK4/6 Inhibitor Resistance in HR-Positive/HER2-Negative Breast Cancer
(MedPage Today) — In the decade since palbociclib (Ibrance) received FDA approval, results from multiple clinical trials have provided a strong evidence base to make cyclin-dependent kinase (CDK)4/6 inhibitors, in combination with endocrine therapy…
New Wegovy pill offers needle-free weight loss — but may not work for everyoneNew Wegovy pill offers needle-free weight loss — but may not work for everyone
The first oral GLP-1 medication for weight loss has been approved for use in the U.S. The Wegovy pill, from drugmaker Novo Nordisk, was cleared by the Food and Drug Administration to reduce excess body weight, maintain long-term weight reduction and lower the risk of major cardiovascular events. Approval of the once-daily 25mg semaglutide pill Read More
Chipotle to offer GLP-1 menu options for customersChipotle to offer GLP-1 menu options for customers
Chipotle to offer GLP-1 menu options for customers Chipotle to offer GLP-1 menu options for customers
Wegovy Pill: Answers to Your Top QuestionsWegovy Pill: Answers to Your Top Questions
While injectable medications have dominated the weight loss space for years, most people aren’t exactly pumped to stick themselves with a needle, so pills like the one from Wegovy could be game-changers. While injectable medications have dominated the weight loss space for years, most people aren’t exactly pumped to stick themselves with a needle, so Read More